SNOA

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.02
Percentage change -0.87	%

Peers: DERM CLDX PBYI XOMA VRNA KURA CUTR ADMA EVOK CBIO

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.05	Insider Own	1.30%	Shs Outstand	1.63M	Perf Week	-3.23%
Market Cap	4.67M	Forward P/E	-	EPS next Y	-0.45	Insider Trans	0.00%	Shs Float	1.62M	Perf Month	-15.58%
Enterprise Value	-0.40M	PEG	-	EPS next Q	-0.51	Inst Own	2.01%	Short Float	1.79%	Perf Quarter	18.05%
Income	-3.46M	P/S	0.33	EPS this Y	41.36%	Inst Trans	36.02%	Short Ratio	0.02	Perf Half Y	4.21%
Sales	14.29M	P/B	1.05	EPS next Y	65.91%	ROA	-24.10%	Short Interest	0.03M	Perf YTD	5.76%
Book/sh	2.70	P/C	0.87	EPS next 5Y	-	ROE	-65.55%	52W High	9.37 -69.65%	Perf Year	-21.06%
Cash/sh	3.27	P/FCF	-	EPS past 3/5Y	58.27% 42.62%	ROIC	-77.90%	52W Low	1.75 62.57%	Perf 3Y	-95.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	4.20% -4.44%	Gross Margin	38.25%	Volatility	3.02% 4.60%	Perf 5Y	-97.95%
Dividend TTM	-	EV/Sales	-0.03	EPS Y/Y TTM	78.92%	Oper. Margin	-25.97%	ATR (14)	0.16	Perf 10Y	-99.82%
Dividend Ex-Date	-	Quick Ratio	2.32	Sales Y/Y TTM	12.19%	Profit Margin	-24.20%	RSI (14)	37.89	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.04	EPS Q/Q	64.94%	SMA20	-8.88%	Beta	1.34	Target Price	14.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	9.16%	SMA50	-11.69%	Rel Volume	0.01	Prev Close	2.87
Employees	168	LT Debt/Eq	0.01	Earnings	Jun 17 AMC	SMA200	-1.84%	Avg Volume	1.16M	Price	2.85
IPO	Jan 25, 2007	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	12,870	Change	-0.87%

Jun-17-25 04:10PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results (ACCESSWIRE)
May-20-25 10:35AM	Tesla's Texas Plan B if Delaware wont reinstate Elon Musk's pay. It's not about the money, says Elon. (Yahoo Finance)
09:34AM	The Texas Plan B if Delaware wont reinstate Elon Musk's Tesla pay haul (Yahoo Finance)
Apr-22-25 04:01PM	Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain (ACCESSWIRE) +69.53%
Mar-27-25 08:50AM	Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain (Zacks) -8.28%
12:44PM	Loading…
Mar-26-25 12:44PM	Delaware passes law designed to stop more Elon Musks from leaving state (Yahoo Finance)
Mar-11-25 08:50AM	Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors (Zacks) +21.86%
Mar-10-25 04:01PM	Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) (ACCESSWIRE) +40.20%
Feb-25-25 04:01PM	Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando (ACCESS Newswire)
Feb-05-25 04:05PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
Dec-05-24 08:30AM	Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices (ACCESSWIRE)
Nov-27-24 08:50AM	Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock (Zacks)
Nov-21-24 04:06PM	Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States (ACCESSWIRE)
Nov-11-24 04:20PM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel (ACCESSWIRE) +10.71% -13.23%
Nov-07-24 08:45AM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results (ACCESSWIRE)
04:01PM	Loading…
Oct-31-24 04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Dusseldorf (ACCESSWIRE) -7.59%
04:01PM	Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf (ACCESS Newswire)
Oct-22-24 08:35AM	Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada (ACCESSWIRE)
Oct-21-24 04:01PM	Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences (ACCESSWIRE) -6.01%
Sep-19-24 08:30AM	Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE) -10.93%
Sep-17-24 08:30AM	Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution (ACCESSWIRE) +23.52%
Sep-11-24 08:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line (ACCESSWIRE)
Aug-28-24 06:10AM	Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock (ACCESSWIRE) -24.99%
Aug-26-24 08:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff (ACCESSWIRE)
Aug-21-24 08:45AM	Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States (ACCESSWIRE) -8.45%
Aug-12-24 07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace) -9.48%
Aug-08-24 04:10PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results (ACCESSWIRE) +13.49% -19.70%
Jul-15-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jul-12-24 07:41AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-09-24 07:30AM	Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine (ACCESSWIRE) -7.27%
08:50AM	Loading…
Jun-28-24 08:50AM	Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock (Zacks)
Jun-18-24 07:37AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) +13.95%
Jun-17-24 09:52PM	SNOA Stock Earnings: Sonoma Pharmaceuticals Misses Revenue for Q4 2024 (InvestorPlace) -5.76%
05:00PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results (ACCESSWIRE)
May-30-24 07:47AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) -21.15%
May-09-24 07:30AM	Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores (ACCESSWIRE)
Apr-09-24 07:30AM	Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States (ACCESSWIRE) +6.33%
Apr-04-24 07:30AM	Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections (ACCESSWIRE)
Mar-28-24 04:01PM	Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences (ACCESSWIRE) -7.88%
Mar-27-24 07:30AM	Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals (ACCESSWIRE)
Feb-08-24 04:10PM	Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Jan-23-24 07:30AM	Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use (ACCESSWIRE)
Jan-09-24 09:15AM	NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonomas Extensive Distributor Network (Business Wire)
Nov-13-23 04:10PM	Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results (ACCESSWIRE) +11.38%
Nov-03-23 07:30AM	Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference (ACCESSWIRE) +8.40%
Oct-26-23 09:10AM	Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock (ACCESSWIRE) -49.83%
Sep-21-23 09:35AM	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference (GlobeNewswire)
Aug-15-23 07:30AM	National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced (ACCESSWIRE)
Aug-10-23 04:15PM	Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results (ACCESSWIRE)
Aug-03-23 07:30AM	Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board (ACCESSWIRE)
Jun-22-23 07:30AM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results (ACCESSWIRE)
Jun-09-23 04:40PM	Sonoma Pharmaceuticals Shares Soar 44% After Introducing New Product (Investopedia) +44.33% -11.43%
Jun-08-23 04:01PM	Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union (ACCESSWIRE) +5.40%
Apr-19-23 01:30PM	Benign Growth For Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Underpins Its Share Price (Simply Wall St.)
Apr-11-23 07:30AM	Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care (ACCESSWIRE)
Mar-28-23 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia (ACCESSWIRE) +15.03% -18.03%
Mar-02-23 07:30AM	Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant (ACCESSWIRE)
Feb-14-23 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results (ACCESSWIRE)
Jan-31-23 07:30AM	Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea (ACCESSWIRE)
Jan-25-23 07:30AM	Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products (ACCESSWIRE) +40.83%
Jan-04-23 07:30AM	Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas (ACCESSWIRE) -6.30%
Nov-17-22 05:33AM	Sonoma Pharmaceuticals Second Quarter 2023 Earnings: US$0.33 loss per share (vs US$0.043 loss in 2Q 2022) (Simply Wall St.)
Nov-14-22 04:15PM	Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results (ACCESSWIRE) +7.21%
Oct-27-22 04:01PM	Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States (ACCESSWIRE)
Oct-06-22 04:15PM	Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany (ACCESSWIRE) -8.81%
Aug-11-22 04:30PM	Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results (ACCESSWIRE)
Aug-02-22 04:30PM	Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply (ACCESSWIRE) +7.96%
Jul-13-22 04:45PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results (ACCESSWIRE)
Jun-01-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce that U.S. EPA has Added Nanocyn® Hospital-Grade Disinfectant to List N for Use Against COVID-19 (Business Wire) -11.59%
May-03-22 06:00AM	Sonoma Pharmaceuticals and MicroSafe Group DMCC Announce EPA Approval for Nanocyn® Hospital-Grade Disinfectant in the U.S. (Business Wire) +31.55%
Mar-30-22 11:20AM	Sonoma Pharma Launches New Urinary Tract Infection Product In New Zealand, Australia, South Africa (Benzinga) +13.39%
06:00AM	Sonoma Pharmaceuticals Launches New Urinary Tract Infection Product Through Distributors in New Zealand, Australia and South Africa (Business Wire)
Feb-11-22 04:30PM	Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results (Business Wire) -6.90%
Jan-28-22 09:38AM	HBC Financial Services, PLLC Buys Apollo Investment Corp, Lockheed Martin Corp, Airbnb Inc, ... (GuruFocus.com)
Jan-20-22 04:40PM	Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China (Business Wire) -10.35%
Jan-05-22 04:55PM	Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022 (Business Wire)
Nov-15-21 08:00AM	Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results (Business Wire)
Nov-09-21 07:00AM	Sonoma Pharmaceuticals and Dyamed Biotech Announce Expanded Long-Term Partnership for New Territories and Products in Southeast Asia (Business Wire)
Oct-15-21 07:44AM	The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO (Benzinga) +5.56%
07:00AM	Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn® Disinfectant & Sanitizer Has Been Approved by the Australia TGA with a 15 Second SARS-CoV-2 (COVID-19) Kill Time (Business Wire)
Sep-30-21 12:50PM	Sonoma Pharmaceuticals (NASDAQ:SNOA) Has Debt But No Earnings; Should You Worry? (Simply Wall St.) -9.27%
Sep-29-21 03:37AM	48 Biggest Movers From Yesterday (Benzinga) -12.02%
Sep-28-21 02:37PM	Mid-Afternoon Market Update: Dow Tumbles 500 Points; Sonoma Pharmaceuticals Shares Spike Higher (Benzinga) +30.65%
12:05PM	Mid-Day Market Update: Nasdaq Down 2.5%; IHS Markit Posts Upbeat Earnings (Benzinga)
07:00AM	Sonoma Pharmaceuticals Launches Its First Over-the-Counter Products in the U.S. on Amazon and a New Consumer-Focused Product on Amazon in Europe (Business Wire)
Aug-20-21 12:19PM	Why Sonoma Pharmaceuticals Shares Are Trading Lower Today (Benzinga) -23.93%
Aug-19-21 01:19PM	Why Sonoma Pharmaceuticals Shares Are Surging Higher Today (Benzinga) +50.65%
09:46AM	Why Sonoma Pharma (SNOA) Stock Skyrocketing On Thursday (Benzinga)
08:23AM	5 Top Stock Gainers for Thursday: Macy's, Nvidia, Sonoma Pharma and Kohl's (TheStreet.com)
07:00AM	Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland (Business Wire)
06:44AM	Sonoma Pharma Stock Doubles on New Dental Products Launch (TheStreet.com)
Aug-16-21 04:15PM	Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results (Business Wire) -6.47%
Jul-15-21 03:51PM	Why Sonoma Pharmaceuticals Shares Are Getting Hammered Today (Benzinga) -17.06%
Jul-14-21 07:56PM	Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results (Business Wire) -13.61%
Mar-31-21 04:10PM	Sonoma Pharmaceuticals and EMC Pharma Announce an Exclusive Partnership to Expand Commercial Channels of the Microcyn®-based Rx Dermatology and Eye Care Products Nationwide (Business Wire) +8.47% +18.44%
Mar-11-21 09:00PM	SONOMA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Is Investigating Sonoma Pharmaceuticals, Inc. on Behalf of Sonoma Stockholders and Encourages Investors to Contact the Firm (Business Wire)
Mar-09-21 08:15PM	ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation SNOA (Business Wire) +5.45%
Mar-04-21 05:03PM	Sonoma Pharmaceuticals to Present at Upcoming Spring Virtual Investor Conferences (Business Wire) -13.80%
Feb-19-21 05:07PM	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Sonoma Pharmaceuticals, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - SNOA (Newsfile) -5.27%
Feb-16-21 05:30PM	Sonoma Pharmaceuticals Reports Third Quarter FY 2021 Financial Results (Business Wire) +5.13%

Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Gottfurcht Grant	10% Owner	Jan 03 '25	Proposed Sale	2.70	86,111	232,500	Jan 03 02:27 PM
Gottfurcht Grant	Open Market	Jan 02 '25	Proposed Sale	2.69	30,000	80,684	Jan 02 03:39 PM
Gottfurcht Grant	Open Market Purchase	Dec 31 '24	Proposed Sale	2.73	17,806	48,562	Jan 02 11:13 AM
Gottfurcht Grant	10% Owner	Aug 09 '24	Proposed Sale	0.26	221,375	56,457	Dec 26 03:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Sonoma Pharmaceuticals Inc

Upgrade your FINVIZ experience